Cancer Research KI News
Research News

November 2021


Tell a colleague about this newsletter

Read the newsletter in your browser

Cancer Research KI updates and upcoming events


Cancer Research KI maps cancer research principle investigators across KI: Database

Cancer Research KI has created a database of cancer principal investigators at KI, which are classified based on diagnostic areas. The aim of the database is to foster new collaborations, learn more about specific cancer areas, or explore industrial interactions.

The first version of the database is already available and it is continuously completed and updated. We would therefore like you to be in contact with us if you find that your name has been erroneously entered, is missing or if you would like to complete the current information in any way. Please send your update request to

For all the details please visit Cancer Research KI website.

Seminars and Workshops


Cancer Research KI retreat at Djurönäset 23rd-24th May 2022

Finally, we can meet again at the XIXth Cancer Research KI Retreat, which will take place May 23-24 2022 at Djurönäset in the Stockholm archipelago. This event gathers cancer researchers from Karolinska Institutet and the University Hospital for an annual joint scientific meeting. The retreat is open for all KI students, post-docs and supervisors with an interest in cancer research and in the Cancer Research KI program, its current and future activities.

We are please to announced that we will have the honour of hosting three keynotes speakers: Nobel prize-winning Sir Gregory Paul Winter from the University of Cambridge, Christina Curtis from Stanford University and William C.Hahn from Dana-Farber Cancer Institute in Boston. There will also be presentations of exciting re­search projects and the traditional lively poster session (with poster prizes!). Some short talks are selected from abstracts- so be sure to submit yours on time and have a chance to present your research!

Registration is now open and the deadline is February 21st. Please remember to send your abstract to (all abstract submission details follow after the registration).

For more information please visit the retreat website. To learn more about the previous editions please visit the retreat archive.

We hope to see you there!


Seminar series on Industrial Collaboration

Save the date

On January 20, 2022, Cancer Research KI launches a new seminar series on Industrial Collaboration. We will discuss topics such as legal issues, commission, collaboration but also there will also be a chance to get inspired by researches, who have already collaborated with industry.

Please let us know if you have suggestions on topics that we should address by sending your ideas to For all the details and a programme for the next seminar please visit our website.

Date: 20 January 2022 | Location: to be confirmed

Karolinska Comprehensive Cancer Center (Karolinska CCC) day

Save the date

On April 1, 2022, Karolinska CCC Day is organised in Aula Medica. The targeted audiences are researchers and clinicians in the field of cancer at Karolinska Institutet and Karolinska University Hospital. Book the day in your calendar and stay tuned for more information about the programme and how to register!

More information will be published on Karolinska CCC website.

Date: 1 April 2022 | Location: Aula Medica, Nobels väg 6, 171 65 Solna

New research administrator at Cancer Research KI


Dagmara Kaczynska has joined Cancer Research KI as a research administrator. Recently, she obtained her Ph.D. at the Department of Medical Biochemistry and Biophysics (MBB) at KI. Now, she will be mostly involved in outreach of the Cancer Research KI organization. Please don't hesitate to contact her if you have any questions or ideas regarding Cancer Research KI.

Warm welcome!

Recent Research Publications


Tatiana A Giovannucci (Dept. of Cell and Molecular Biology) et al., Identification of a novel compound that simultaneously impairs the ubiquitin-proteasome system and autophagy. Autophagy. 2021 Nov.

Ani Azatyan (Dept. of of Biosciences and Nutrition) et al., Circular RNAs in Hedgehog Signaling Activation and Hedgehog-Mediated Medulloblastoma Tumors. Cancers (Basel). 2021 Oct.

Anders Lideståhl (Dept. of Oncology-Pathology) et al,. Estimated Risk of Radiation-Induced Cancer after Thymoma Treatments with Proton- or X-ray Beams. Cancers (Basel). 2021 Oct.

Sandra Wessman (Dept. of Oncology-Pathology) et al,. Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing. Cancers (Basel). 2021 Oct.

Daniel W Hagey (Dept. of Laboratory Medicine) et al., Extracellular vesicles are the primary source of blood-borne tumour-derived mutant KRAS DNA early in pancreatic cancer. J Extracell Vesicles. 2021 Oct.

Yunzhang Wang (Dept. of Medical Epidemiology and Biostatistics) et al., Improved breast cancer histological grading using deep learning. Annals of Oncology. 2021 Sep.

Felix Grassmann (Dept. of Medical Epidemiology and Biostatistics) et al., Mammographic features are associated with cardiometabolic disease risk and mortality. Eur Heart J. 2021 Sep.

Thomas Hatschek (Dept. of Oncology-Pathology) et al., Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2021 Sep.

Any cancer-related publications from a KI-based researcher (corresponding author must be from KI) that you wish to be advertised through our newsletter please send in the format shown above to our email:

Grant Announcements

Cancer Research KI awards research grants in several categories to promote excellent young researchers, clinical research, innovative research and joint international research projects. All grants are announced openly and the applications undergo external review.

Open Positions


Please send us your open positions for Master projects, PhD candidates and postdocs so that we can advertise them to our Cancer Research KI community.

Facebook Twitter Cancer Research KI Homepage

Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, conducted by some 350 research groups at multiple campuses and departments. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the overall goal to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.


Do not click this link